
Juan D. Gomez
@JDGomezMD
Followers
2K
Following
13K
Media
131
Statuses
1K
Gastroenterologist at @UMiamiHealth. Trained at @BCM_gihep and @ClevelandClinic. Colombian 🇨🇴. @UniJaveriana alum
Miami, FL
Joined October 2018
@JDGomezMD @CarlKayMD 1️⃣ Way to go 🙌🏻 👌🏻 That’s the way we were taught at Univ. of Alabama, where pathologist Dr. A. Lazenby moved to work, a few years after discovering microscopic colitis
1
1
4
Todo um derroche de creatividad….. danza Kuduro….. los Rafa Nadal…. LOL
Late Breaking Trial about Dapaglifoxin in Px with TAVI. What a way to present with music !!! #SoMe @ACCinTouch
0
0
0
Happy to participate in the @AmerGastroAssn official newspaper with this article I wrote on GERD lifestyle modifications, check it out!
Do lifestyle changes still apply in the treatment of #GERD? In our latest Perspectives piece, @JDGomezMD highlights the benefits of lifestyle changes, while Dr. Brijesh B. Patel examines the ubiquitous use of PPIs. https://t.co/MDwi4Ts3pQ
@Aketwaroo
3
6
15
Glad to find that out BCM model has performed well in external validation: 👇🏻👇🏻👇🏻 “BCM model was the only score that proved to be an independent predictor of both ER and LR, proving to be valuable for both applications” https://t.co/R6IjL6P1SC
pubmed.ncbi.nlm.nih.gov
We present the first external validation of the three scores mentioned in an European cohort. SERT and BCM scores had an acceptable performance in predicting ER and LR. However, the BCM model was the...
0
0
3
This was a research project when I was a fellow at @bcm_gihep, where the mentorship is outstanding. https://t.co/WooxDxnPA8
pubmed.ncbi.nlm.nih.gov
SERT score and mSMSA have poor external validity to predict polyp recurrence after EMR of non-pedunculated polyps > 20 mm. Our new model is simpler and performs better in this multiethnic, non-refe...
1
3
21
3 published scores to predict the risk of polyp recurrence after EMR of large colonic polyps 1. Baylor College of Medicine BCM 2. SMSA size, morphology, site and access 3. SERT Sydney EMR recurrence tool BCM has been externally validated in 2 different European cohorts:
Baylor College of Medicine (BCM) model predicts recurrence after mucosectomy of colorectal lateral spreading tumors in European cohorts @JDGomezMD @thrift_dr
@Aketwaroo
https://t.co/K34U90wdZP
1
1
7
Severe Drug-Induced Liver Injury Due to Self-administration of the Veterinary Anthelmintic Medication, Fenbendazole https://t.co/ZgaAZATXtW
pubmed.ncbi.nlm.nih.gov
Fenbendazole is an anthelmintic agent approved for veterinary applications. Even though it is not approved by the US Food and Drug Administration for human use, such use appears to be increasing due...
0
0
2
Case reports: Drug-Induced Liver Injury in a Patient with Nonsmall Cell Lung Cancer after the Self-Administration of Fenbendazole Based on Social Media Information https://t.co/9QKqyAZnaA
pubmed.ncbi.nlm.nih.gov
Fenbendazole is a benzimidazole anthelmintic agent, with a broad antiparasitic range in animals such as dogs and pigs. The agent is also reported to exert antitumor effects and inhibit microtubule-...
1
0
2
Cancer patient with severe acute liver injury? 🚨 🚨🚨🚨🚨🚨🚨🚨🚨 Add this one to your differential: Fake information online with presumed anti-cancer benefits of FENBENDAZOLE is prompting cancer patient to take this veterinarian antiparasitic.
1
2
4
This is so true and applies 100% to Colombia
Raising a child in the US seems hellish compared to India. US—Wake up early, cook, drive kid to work, both parents work, do groceries, chores, cleaning. Lonely. India—Maid cleans, driver drops you, groceries in 15mins, cook cooks, parents babysit. Community. (requires $$) 1/4
1
0
7
This study (PMID: 36610497 on @AGA_CGH sept) acknowledge the great diversity within hispanics. Mexicans and Ecutorians had the worst profile of liver disease risk (High PNPLA3 and low HSD17B13 ->protective). Both have larger indigenous pop compared with the other countries.
1
0
9
Carvedilol is becoming the King 👑 for all indications
Study finds carvedilol achieves higher hemodynamic response and lower rebleeding rates than propranolol in secondary prophylaxis. Check out the full article here: https://t.co/qukm1hTqD5
0
2
9
Van a terminar echándole GLP-1 al agua
Late breaking at #ESCCongress: In patients with heart failure with preserved ejection fraction and obesity, semaglutide (2.4 mg) led to greater reductions in symptoms and physical limitations and greater improvements in exercise function than placebo. Full STEP-HFpEF trial:
2
2
19